Lilly(Eli) & Company
NYSE: LLY
$754.16
+$6.15 (+0.8%)
Closing Price on November 25, 2024
LLY Articles
Friday morning’s analyst upgrades and downgrades included Adobe, Alcoa, Ally Financial, AppLovin, Block, Eli Lilly, Luminar Technologies, Novavax, Twilio, Wendy's, Zoom Video Communications and...
Published:
The bear market rally that started in June is over and it is clearly a time to move to safer dividend stocks. These eight outstanding health care stocks make sense for worried investors now as they...
Published:
Monday’s additional top analyst upgrades and downgrades were on American Express, Aurora Cannabis, Edison International, Eli Lilly, PayPal, Upwork and more.
Published:
J.P. Morgan takes a look at a few stocks with potentially huge upside and where they could go in light of a possible recession.
Published:
Tuesday's top analyst upgrades and downgrades included Alibaba, American Express, Amgen, Blue Owl Capital, Boeing, Carnival, CoStar, Deere, eBay, Eli Lilly, Foot Locker, Home Depot, Juniper Networks,...
Published:
Wednesday's top analyst upgrades and downgrades included AbbVie, Blackstone, Boston Scientific, CarMax, Chewy, Eli Lilly, Medtronic, NetApp, Ping Identity, Shopify, Veru and Zscaler.
Published:
Thursday's top analyst upgrades and downgrades included Analog Devices, Eli Lilly, Fastenal, Global Payments, Keurig Dr Pepper, Lululemon Athletica, Merck, Occidental Petroleum, Rivian Automotive and...
Published:
A recent survey of global fund managers found that many have turned to health care for some stability in these uncertain times. These eight high-dividend-paying stocks are rated Buy at top Wall...
Published:
Thursday's top analyst upgrades and downgrades included Arista Networks, Bumble, Cisco Systems, ConocoPhillips, CrowdStrike, DXC Technology, Eli Lilly, Emerson Electric, Freeport-McMoRan,...
Published:
Given Warren Buffet's proclivity for only owning stock of companies that he understands inside and out, these 10 top health care picks with big, dependable dividends make sense now for growth and...
Published:
A few big biopharma names were on the move Tuesday morning, and analysts were taking their shot at them.
Published:
Friday afternoon's top analyst upgrades and downgrades included Baker Hughes, CSX, Eli Lilly, Netflix, Peloton, Under Armour and more.
Published:
The three major U.S. stock indexes are trading lower again in Friday's premarket session.
Published:
Tuesday's top analyst upgrades and downgrades included Broadcom, Carrier Global, Canadian Pacific Railway, Coca-Cola, Eli Lilly, Marvell Technology, Pfizer, Regions Financial, Stryker, Synchrony...
Published:
Thursday's top analyst upgrades and downgrades included AT&T, Abbott Laboratories, Advanced Micro Devices, Affirm, Canopy Growth, Cleanspark, Eli Lilly, ESS Tech, Global Payments and Luminar...
Published: